Table 3 Comparison between the clinically good and poor responders
Characteristics | Clinically good (CR/PR/SD) | Clinically poor (PD) | p-value |
|---|---|---|---|
Number of patients | 26 | 16 | Â |
Age (years) | 61.6 (37-81) | 65.6 (43-81) | p = 0.2434 |
Sex |  |  | p = 0.7513 |
 Males | 12 | 9 |  |
 Females | 14 | 7 |  |
Stage |  |  | p = 0.0735 |
 III | 12 | 2 |  |
 IV | 9 | 10 |  |
 Recurrence | 5 | 4 |  |
Liver metastasis (pretreatment) |  |  | p = 0.0081 |
 Absence | 25 | 10 |  |
 Presence | 1 | 6 |  |
NLR | 2.3 (0.7-6.4) | 3.1 (0.4-6.1) | p = 0.1364 |
Number of CTLs (x108/time) | 7.0 (2.8-12.4) | 5.1 (1.0-9.0) | p = 0.0537 |
Number of DCs (x107/time) | 2.1 (0.9-3.9) | 1.2 (0.04-2.9) | p = 0.0015 |